In oral squamous cell carcinoma (OSCC) [59] and colorectal cancer (CRC) [60], tumor cells exhibit high expression of CCL26, with elevated levels promoting epithelial–mesenchymal transition (EMT) and correlating with poorer survival. This evidence concerns the gene CCL26 and neoplasm.